loadpatents
Patent applications and USPTO patent grants for NASH; Kevin R..The latest application filed is for "recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases".
Patent | Date |
---|---|
Recombinant Adeno-associated Virus-mediated Expression Of Fractalkine For Treatment Of Neuroinflammatory And Neurodegenerative Diseases App 20210130429 - GEMMA; Carmelina ;   et al. | 2021-05-06 |
Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases Grant 10,815,285 - Gemma , et al. October 27, 2 | 2020-10-27 |
Recombinant Adeno-associated Virus-mediated Expression Of Fractalkine For Treatment Of Neuroinflammatory And Neurodegenerative Diseases App 20140205570 - Gemma; Carmelina ;   et al. | 2014-07-24 |
Production of pseudotyped recombinant AAV virions Grant 7,094,604 - Snyder , et al. August 22, 2 | 2006-08-22 |
RAAV-neprilysin compositions and methods of use App 20050271625 - Nash, Kevin R. ;   et al. | 2005-12-08 |
Production of pseudotyped recombinant AAV virions App 20040209245 - Snyder, Richard O. ;   et al. | 2004-10-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.